A 57-year-old male patient with a history of coronary artery disease presents with increased chest pain frequency and intensity, now occurring at rest. His vital signs include a blood pressure of 155/98 mmHg, heart rate of 105 bpm, and oxygen saturation of 90% on room air. ECG shows ST-segment depression, and troponin levels are elevated. Which nursing intervention is the highest priority to address the patient's current condition?

A) Administer supplemental oxygen to improve oxygen saturation.

C) Prepare the patient for immediate coronary angiography.

D) Educate the patient on lifestyle modifications to manage elevated LDL levels.

A 57-year-old male patient with a history of chest pain now presents with increased frequency of pain at rest, elevated blood pressure, tachycardia, and low oxygen saturation. An ECG shows ST-segment depression and elevated troponin levels. What is the most appropriate initial nursing intervention to optimize oxygen delivery to the myocardium?

A) Administer supplemental oxygen to maintain oxygen saturation above 94%

B) Encourage the patient to perform deep breathing exercises to reduce anxiety

C) Position the patient in a high-Fowler's position to decrease cardiac workload

D) Administer a beta-blocker to reduce heart rate and myocardial oxygen demand

A patient with unstable angina and newly diagnosed acute decompensated heart failure is being treated with diuretics, ACE inhibitors, and supplemental oxygen. Which of the following nursing interventions is most critical to monitor the effectiveness of the treatment for this patient?

A) Measuring daily weight to assess fluid balance

B) Monitoring blood glucose levels for hyperglycemia

C) Checking liver function tests for ACE inhibitor side effects

D) Assessing peripheral pulses for circulatory status

A patient with unstable angina and newly diagnosed acute decompensated heart failure is being treated with diuretics, an ACE inhibitor, and supplemental oxygen. Which assessment finding would indicate that the treatment plan is effective in addressing the patient's heart failure symptoms?

C) Oxygen saturation improves to 94% on room air

A) Blood pressure decreases to 140/90 mmHg

B) Heart rate increases to 110 bpm

C) Oxygen saturation improves to 94% on room air

D) Presence of bilateral crackles on auscultation

A patient with acute heart failure and hypokalemia secondary to diuretic therapy is experiencing a new onset of atrial fibrillation. Which nursing intervention should be prioritized to address the patient's current condition?

C) Administer a rate-controlling medication to manage atrial fibrillation.

A) Administer potassium supplementation as prescribed to correct hypokalemia.

B) Initiate oxygen therapy to further increase oxygen saturation levels.

C) Administer a rate-controlling medication to manage atrial fibrillation.

D) Encourage the patient to perform deep breathing exercises to reduce anxiety.

A patient with acute heart failure is undergoing diuretic therapy and supplemental oxygen. The patient develops hypokalemia with a potassium level of 3.1 mmol/L and experiences a transient episode of atrial fibrillation with a heart rate of 130 bpm. Which nursing intervention is most appropriate to prioritize at this time?

B) Administer potassium supplementation as ordered to correct hypokalemia.

A) Increase the flow rate of supplemental oxygen to 6 L/min to improve oxygenation.

B) Administer potassium supplementation as ordered to correct hypokalemia.

C) Begin cardioversion to immediately address the atrial fibrillation.

D) Educate the patient about reducing fluid intake to manage fluid overload.

A patient with a history of atrial fibrillation has been started on a rate-controlling medication. After 12 hours, their heart rate stabilizes, but they report increased fatigue and dizziness when sitting up, and their blood pressure has dropped to 110/70 mmHg. Which nursing intervention is most appropriate to address the patient's symptoms and ensure safety?

B) Educate the patient on the importance of slow positional changes

A) Increase fluid intake to raise blood pressure

B) Educate the patient on the importance of slow positional changes

C) Administer additional potassium supplements to prevent arrhythmias

D) Encourage the patient to exercise to improve cardiac output

A patient with atrial fibrillation and heart failure has been stabilized on rate-controlling medication. After 12 hours, the patient develops fatigue and dizziness upon sitting up, with a blood pressure reading of 110/70 mmHg. Which nursing intervention should be prioritized to address these symptoms?

B) Educate the patient on performing slow positional changes to prevent orthostatic hypotension.

A) Increase the dose of the rate-controlling medication to further stabilize heart rate.

B) Educate the patient on performing slow positional changes to prevent orthostatic hypotension.

C) Encourage the patient to increase fluid intake to counteract hypotension.

D) Discontinue the rate-controlling medication and notify the healthcare provider immediately.

A patient with atrial fibrillation is experiencing mild pulmonary congestion and a decreased ejection fraction. Which nursing intervention should be prioritized to address the patient's respiratory distress while managing fluid status?

B) Administer the ordered diuretics to reduce pulmonary congestion.

A) Increase the patient's fluid intake to promote renal perfusion.

B) Administer the ordered diuretics to reduce pulmonary congestion.

C) Encourage deep breathing and coughing exercises to improve oxygenation.

D) Discontinue oxygen therapy to assess the patient's baseline respiratory function.

A patient with newly developed pulmonary congestion and reduced ejection fraction is on supplemental oxygen therapy. To optimize the patient's respiratory and cardiac status, what is the most appropriate nursing intervention?

C) Adjust the patient's position to high Fowler's to facilitate breathing.

A) Increase the oxygen flow rate to 4 liters per minute.

B) Encourage the patient to ambulate frequently to improve lung expansion.

C) Adjust the patient's position to high Fowler's to facilitate breathing.

D) Administer a dose of bronchodilator to ease respiratory distress.

angina - Nursing Case Study

Pathophysiology

• Primary mechanism: Angina is primarily caused by reduced blood flow to the heart muscle due to atherosclerosis, where plaque buildup narrows coronary arteries, leading to decreased oxygen supply (ischemia) during increased demand, such as physical exertion.

• Secondary mechanism: Coronary artery spasm can also contribute to angina by transiently narrowing the arteries, reducing blood flow and oxygen delivery to the heart muscle, even without significant atherosclerosis.

• Key complication: Chronic ischemia can lead to myocardial infarction if blood flow is severely restricted or completely blocked, causing irreversible damage to the heart tissue and increasing the risk of heart failure.

Patient Profile

Demographics:

57-year-old male, construction worker

History:

• Key past medical history: Hypertension, hyperlipidemia, type 2 diabetes

• Current medications: Metoprolol, atorvastatin, metformin, aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain

• Key symptoms: Chest tightness radiating to the left arm, shortness of breath, fatigue

• Vital signs: Blood pressure 150/95 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the clinical team continues to assess the 57-year-old male patient, his condition begins to evolve, presenting new challenges that require careful attention and intervention. During a follow-up evaluation, the patient reports an increase in the frequency and intensity of his chest pain episodes, which now occur even at rest. This change in symptom pattern raises concerns for unstable angina, indicating that his condition may be progressing towards a more serious cardiac event. His vital signs show a slight increase in blood pressure to 155/98 mmHg and tachycardia with a heart rate of 105 bpm. Oxygen saturation remains concerning at 90% on room air.

In light of these changes, the healthcare team orders a series of diagnostic tests to better understand the underlying causes of the patient's deteriorating status. An ECG reveals ST-segment depression, which is indicative of subendocardial ischemia and suggests that the myocardial oxygen supply is significantly compromised. Laboratory results show elevated troponin levels, confirming myocardial injury and increasing the suspicion of an impending myocardial infarction. The patient's lipid profile remains abnormal, with elevated LDL cholesterol levels, reinforcing the need for aggressive management of his atherosclerotic risk factors.

Given these findings, the clinical team must employ critical reasoning to determine the most appropriate interventions. The priority is to stabilize the patient by optimizing oxygen delivery to the heart and preventing further ischemic damage. Adjustments to his medication regimen are considered, including the potential addition of a calcium channel blocker to alleviate coronary artery spasm and improve coronary blood flow. Additionally, the team discusses the possible need for coronary angiography to evaluate the extent of coronary artery disease and consider revascularization options. The patient's evolving condition underscores the importance of a dynamic and responsive treatment plan to mitigate the risk of a full-blown myocardial infarction and preserve cardiac function.

Section 2

As the clinical team implements the revised treatment plan, including the introduction of a calcium channel blocker, the patient initially shows signs of improvement. His chest pain episodes decrease in frequency, and his heart rate stabilizes around 90 bpm. However, within 48 hours, the patient experiences a sudden onset of severe dyspnea and orthopnea, prompting an immediate reassessment. His oxygen saturation has dropped further to 85% on room air, and auscultation reveals new bilateral crackles at the lung bases, suggesting the development of pulmonary congestion. The patient's blood pressure has increased to 160/100 mmHg, and he appears anxious and diaphoretic.

Given these alarming changes, the healthcare team suspects acute heart failure, likely precipitated by the ongoing myocardial ischemia and possible left ventricular dysfunction. A chest X-ray confirms pulmonary edema, showing diffuse interstitial and alveolar infiltrates. An urgent echocardiogram is ordered, revealing a reduced ejection fraction of 35%, indicative of compromised left ventricular contractility. This new complication necessitates a reevaluation of the patient's management strategy, with a focus on acute decompensated heart failure.

In light of these findings, the clinical team initiates diuretic therapy to reduce fluid overload and considers the addition of an ACE inhibitor to support heart function and control blood pressure. The patient is placed on supplemental oxygen to improve his hypoxemia. The situation demands vigilant monitoring to assess the response to these interventions and to prevent further deterioration. This development highlights the complexity of managing unstable angina with concurrent heart failure, emphasizing the need for continuous assessment and adaptation of the treatment plan to address evolving clinical challenges.

Section 3

As the patient begins diuretic therapy and supplemental oxygen, the clinical team closely monitors his response to these interventions. Within a few hours, there is a noticeable reduction in his fluid overload; the patient begins to diurese effectively, with urine output increasing to 100 mL/hour. His oxygen saturation improves to 92% with supplemental oxygen via nasal cannula at 4 L/min, and his respiratory distress begins to subside slightly, although he still experiences mild orthopnea. The patient's blood pressure shows signs of stabilization, decreasing to 145/90 mmHg, but he remains anxious, and his diaphoresis persists.

Laboratory results return, showing elevated levels of brain natriuretic peptide (BNP) at 650 pg/mL, confirming the suspicion of acute heart failure. Serum electrolytes reveal hypokalemia, with a potassium level of 3.1 mmol/L, likely secondary to the diuretic therapy. This necessitates the initiation of potassium supplementation to prevent further complications, such as arrhythmias. The team also reviews the echocardiogram findings, which indicate moderate mitral regurgitation, contributing to the patient's heart failure symptoms. This finding will require further evaluation and management as part of the long-term strategy.

Despite these initial positive responses, the patient experiences a transient episode of atrial fibrillation, with a heart rate spiking to 130 bpm. This new arrhythmia poses an additional challenge, potentially exacerbating his cardiac workload and compromising cardiac output further. The clinical team decides to initiate rate-controlling medication to manage the atrial fibrillation and prevent further hemodynamic instability. This development underscores the complexity of his condition, requiring ongoing adjustments to the treatment plan to address both the heart failure and rhythm disturbances effectively. The team remains vigilant, recognizing that the patient's journey will require careful coordination and frequent reassessment to navigate the intricate interplay of his cardiac issues.

Section 4

As the clinical team continues to monitor the patient's response to the implemented interventions, they observe a change in his status that necessitates further clinical reasoning and action. Approximately 12 hours after the initiation of rate-controlling medication for atrial fibrillation, the patient's heart rate stabilizes to around 85 bpm. His anxiety diminishes slightly as his cardiac workload decreases, thereby improving his comfort level. However, the patient now reports increased fatigue and dizziness upon attempting to sit up in bed, prompting the team to conduct a thorough reassessment to understand the underlying cause of these new symptoms.

Vital signs now reveal a blood pressure of 110/70 mmHg, indicating a significant drop from earlier readings. This hypotension suggests a potential over-response to the rate-controlling medication, necessitating an adjustment in dosage to maintain hemodynamic stability. Additionally, the patient's serum potassium level has improved to 3.5 mmol/L following the potassium supplementation, which alleviates some concern over immediate arrhythmia risks but still requires ongoing monitoring.

With these findings, the team implements changes to the patient's treatment plan, opting to cautiously adjust the rate-controlling medication dosage while maintaining close observation of his blood pressure and cardiac rhythm. They emphasize the importance of gradual positional changes to mitigate orthostatic hypotension and continue to monitor for signs of improved fluid balance and oxygenation. This phase of the patient's journey highlights the need for a delicate balance in managing heart failure symptoms alongside the complexities introduced by atrial fibrillation, demonstrating the necessity for an adaptive and patient-centered approach to care.

Section 5

As the clinical team continues to assess the patient's condition, they observe a new complication emerging. Approximately 24 hours after the initial intervention, the patient begins to exhibit signs of mild respiratory distress, characterized by increased respiratory rate and occasional bouts of coughing. His oxygen saturation has decreased slightly to 92% on room air, prompting the team to initiate supplemental oxygen therapy at 2 liters per minute via nasal cannula to maintain adequate oxygenation. A focused respiratory assessment reveals crackles in the lower lung fields bilaterally, suggesting the development of pulmonary congestion.

In light of these findings, the team orders a chest X-ray and an echocardiogram to evaluate for possible worsening heart failure and to assess left ventricular function. The chest X-ray confirms mild pulmonary edema, while the echocardiogram shows a further reduction in ejection fraction to 35%, indicating compromised cardiac output. These results point to a delicate balancing act between managing atrial fibrillation and avoiding fluid overload, which has now become a significant concern.

To address the pulmonary congestion while maintaining rate control, the team considers adjusting the patient's diuretic regimen to facilitate fluid removal and alleviate pulmonary symptoms. Additionally, they reinforce the importance of fluid restriction and sodium management in the patient's dietary plan. This phase of the patient's journey underscores the complexity of managing coexisting cardiovascular conditions and highlights the critical need for consistent reevaluation and tailored interventions to optimize outcomes.